Close

Goldman Sees Catalysts for Cree (CREE); 'Co. Navigated Q2 Well'

Go back to Goldman Sees Catalysts for Cree (CREE); 'Co. Navigated Q2 Well'

Cree (CREE) Numbers Trimmed at Northland Capital Markets Post Q2

January 22, 2014 8:39 AM EST

Northland Capital Markets trimmed estimates and its price target on Market Perform-rated Cree (NASDAQ: CREE) from $61 to $59 following Q2 results and outlook.

"We remain on the sidelines with CREE shares given our view that operating leverage will be challenging as the company... More

Cree (CREE) Q2 Solid, But Guidance Seasonally Soft - Needham & Company

January 22, 2014 7:28 AM EST

Needham & Company analyst Y. Edwin Mok reiterated a Hold rating on Cree (NASDAQ: CREE) following "good" Q2 results but seasonally soft guidance.

"Cree delivered a strong F2Q14 report but provided seasonally softer guidance that is below consensus," Mok comments. "Given the... More

Cree, Inc. (CREE) Posts Q2 EPS of 46c; Issues Q3 Outlook

January 21, 2014 4:02 PM EST

Cree, Inc. (NASDAQ: CREE) reported Q2 EPS of $0.46, versus the analyst estimate of $0.39. Revenue for the quarter came in at $415.09 million versus the consensus estimate of $412.36 million.

Cree, Inc. sees Q3 2014 EPS of $0.34-$0.41, versus the consensus of $0.4. Cree, Inc. sees Q3 2014 revenue... More